Oncolytics Biotech Announces Voting Results from the Annual General Meeting of Shareholders

SAN DIEGO and CALGARY, AB, May 10, 2021 /PRNewswire/ -- Oncolytics Biotech Inc. (NASDAQ: ONCY) (TSX: ONC), today announced the voting results from its Annual General Meeting of Shareholders held on Friday, May 7, 2021. A total of 41.41% of the issued and outstanding common shares of the Corporation were represented either in person or by proxy at the meeting.

 

 

On a vote by ballot, the following seven nominees proposed by the Corporation were elected as Directors of Oncolytics to serve until the Corporation's next Annual Meeting of Shareholders or until their successors are elected or appointed, with shares represented at the meeting voting in favor of individual nominees as follows:

 

Director	For	%	Withheld	%
Deborah M. Brown	5,247,713	82.43%	1,118,493	17.57%
Matthew C. Coffey	5,084,018	79.86%	1,282,188	20.14%
Angela Holtham	5,236,090	82.25%	1,130,116	17.75%
Leonard Kruimer	5,290,086	83.10%	1,076,120	16.90%
Wayne Pisano	5,217,168